Goodsurance
ES

Drug prices & Part D

Zero-Premium Part D Drug Plans Disappear in 2027, Leaving 4 Million Enrollees Without the Free Option They Had This Year

A KFF analysis published the day plan shopping opened finds no standalone Medicare drug plan will be offered at zero monthly cost to non-subsidized enrollees in 2027, and some face increases of 50 dollars or more per month if they do not switch.

By the Goodsurance editorial teamOctober 2, 2026

A KFF analysis published October 2, 2026, finds that for the first time, no standalone Medicare prescription drug plan will be offered at zero monthly premium to enrollees who do not receive the low-income subsidy. In 2026, about 4 million non-subsidized enrollees, roughly 28 percent of all standalone drug plan members without extra help, paid nothing per month for their coverage. Every one of those enrollees will pay something in 2027.

For most plan holders, the change will be modest. The federal benchmark average monthly premium across standalone plans is projected to rise less than 1 dollar, from 35.09 dollars to 36 dollars. Many enrollees can keep their increase small by actively comparing options and switching to a lower-cost alternative during open enrollment.

Zero-premium Part D plans are gone for 2027. Four million Medicare enrollees need to shop before December 7.

The stakes are higher for those who do not shop. KFF found that for at least one major branded plan, enrollees who keep their current coverage could face monthly increases of 50 dollars or more in all 50 states and Washington D.C. The count of standalone plan options available to the average beneficiary continues to fall, reaching 9 in 2027, down from 11 in 2026, part of a four-year decline. That plan is AARP Medicare Rx Preferred. The two AARP plans together cover more than 2 million people who do not get Extra Help. Rx Preferred premiums rise by more than 75 dollars a month in 37 states and more than 100 dollars in 4 states. AARP Medicare Rx Saver rises by 50 dollars or more in 33 states. Lower-cost options exist: Wellcare Value Script costs 5.30 dollars a month in 45 states, and Wellcare Classic costs 7.30 dollars in 33 states.

The annual Medicare open enrollment period begins October 15 and closes December 7, 2026. All plan changes take effect January 1, 2027.

In plain words

In 2027, there will be no Medicare drug plans that cost zero per month for people who do not get extra help paying for Medicare. About 4 million people paid nothing for their drug plan in 2026. All of them will have to pay something next year. If you shop for a cheaper plan, the change may be less than 1 dollar a month. But if you stay in certain plans without comparing, you could pay 50 dollars more each month. There are also fewer plans to pick from. Open enrollment runs October 15 to December 7.

Source: KFF
Read at the source →

More news

Other stories on what is moving in Medicare.

Drug prices & Part D

Medicare Part D Rarely Covers the OTC Naloxone Nasal Spray. Medicaid Usually Does.

A new Government Accountability Office report finds that most Part D plans stopped covering the over-the-counter naloxone nasal spray after it no longer required a prescription, while Medicaid covers the same product at little or no cost to enrollees.

November 16, 2026

Drug prices & Part D

Biotech Industry Group Files Second Lawsuit to Block Medicare's GLOBE Drug Pricing Model

BIO and two California biotech groups sued CMS on November 6, arguing the program exceeds legal authority. A first challenge from PhRMA filed in October remains pending.

November 12, 2026

Drug prices & Part D

KFF: Medicare's 340B Drug Payment Cut Reduces Revenue for Safety-Net Hospitals While Raising It for For-Profit Ones

Now that the 2027 outpatient rule is final, a KFF analysis finds the 340B reimbursement cut falls hardest on hospitals that serve low-income patients, while for-profit hospitals see a net gain.

November 11, 2026

Drug prices & Part D

Medicare Drug Price Negotiation Rules Are Now Permanent, Federal Register Shows

The CMS-4215-F final rule, published today, converts the negotiation program from administrative guidance into binding federal regulation for every drug-price cycle starting in 2029, and requires Part D plans to cover negotiated-price drugs on their formularies.

November 9, 2026

Drug prices & Part D

Third Medicare Drug Negotiation Cycle Closes, Including Part B Doctor-Office Drugs for the First Time

The formal negotiation period for 15 drugs ended November 1; CMS must publish any agreed-upon maximum fair prices by November 30, including the first-ever negotiated prices for drugs given in doctors' offices.

November 1, 2026

Drug prices & Part D

Average Medicare Part D Stand-Alone Premium Projected to Rise 50 Percent for 2027, KFF Finds

A KFF analysis published today finds the average monthly premium for stand-alone Part D drug plans is on track to climb from 34 dollars to 51 dollars for 2027, with deductibles also rising sharply, for enrollees who do not switch plans before December 7.

October 30, 2026